To assess the antibody responses to SARS-CoV-2 N-protein, the IgA and IgG levels were compared at one to eight days post-onset of COVID-19 symptoms and then at two or three intervals in the follow-up visits of the SARS-CoV-2 rT-PCR positive COVID-19 patients (Figure 3). Here, CD79A is linked to COVID-19.